SLN
Silence Therapeutics Plc
Stock NASDAQ – Stock Market Prices, News & Analysis
Silence Therapeutics Plc is engaged in the development of gene therapies based on siRNA technologies to treat serious diseases.
Silence Therapeutics Plc
SLN
Silence Therapeutics Plc is engaged in the development of gene therapies based on siRNA technologies to treat serious diseases.
Price history of Silence Therapeutics Plc
Price history of Silence Therapeutics Plc
Performance & Momentum
Strategic Analysis
Silence Therapeutics Plc • 2026
Silence Therapeutics is a niche biopharmaceutical company focused on RNA interference-based drugs, an approach designed to selectively silence specific genes that cause disease. Its positioning is built on a differentiated platform technology in innovative medicine, with significant potential if the clinical programs confirm their therapeutic value.
- Differentiated siRNA technology, positioned in a scientific segment with strong medical potential
- Exposure to the innovative medicines theme, which could create value if clinical trials are successful
- Solid stock momentum, reflecting a renewed market interest in the name
- Inherently risky biotech profile, heavily dependent on clinical and regulatory outcomes
- Mixed long-term performance history, indicating high volatility and still uneven value creation
Momentum appears favorable and clearly improved, with recent sustained strength suggesting a re-rating of the stock by the market. This trend is positive for tactical investors, but it still needs to be confirmed by clinical progress and consistent execution in an environment where fundamental visibility remains limited.
Similar stocks to Silence Therapeutics Plc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
